Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Quince Therapeutics

QNCX

----

OverviewOverview NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

Quince Therapeutics (QNCX)

Quince Therapeutics, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare d...

Open: --
High: --
Low: --
Prev. Close: --
Volume: --
Turnover: --
Avg Price: --
Bid/Ask Ratio: --
Amplitude: --
52wk High: --
Volume Ratio: --
Turnover Ratio: --

52wk Low: --
Float Mkt Cap: --
Market Cap: --
P/E^TTM: --
P/E^Dynamic: --
P/E^Static: --
EPS^TTM: --
EPS^Dynamic: --
EPS^Static: --
BVPS: --
P/B: --
Circulating Supply: --
Dividend Yield^TTM: --
Dividend^TTM: --
Shares: --
Min lot size: --
Currency: --

Quince Therapeutics Analyst Rating

Forecast & Rating

Sep 8, 2026

Price forecast

$77.20161.25%

Forecast & RatingBuy

7analysts

Strong buy71.43%
Buy0.00%
Hold28.57%
Sell0.00%
Strong sell0.00%

Strong buy: 5
Buy: 0
Hold: 2
Sell: 0
Strong sell: 0

News

Global Report · Sep 9 at 10:12 AM
The Unbundled Margins: Why Niche Markets Defy Aggregation Theory
PUBT · Sep 4 at 12:30 PM
Quince Therapeutics flags Nasdaq noncompliance after stockholders’ equity falls to ($35.32 million)
Unusual Whales · Sep 3 at 12:02 PM
Quince Therapeutics to Participate in September 2026 Investor Conferences
PUBT · Sep 3 at 12:02 PM
Quince Therapeutics to present at Cantor Global Healthcare Conference